This school examines mast cell activation syndrome (MCAS), histamine intolerance, immune dysregulation, and the overlap between mast cell dysfunction and chronic inflammatory conditions. MCAS is commonly seen alongside CIRS, Lyme, and environmental illness. The school provides education on how mast cells function, what triggers activation, and how immune dysregulation patterns may intersect with biotoxin and inflammatory illness.
Educational content on mast cell activation, histamine, immune dysregulation, and overlap with inflammatory and biotoxin illness.
Anticipated release: January 2027.
Understanding histamine and the many mediators released by mast cells, and how they drive diverse symptoms throughout the body. Anticipated release: January 2027.
Foundational education on immune dysregulation patterns and how they connect to chronic inflammatory and biotoxin illness. Anticipated release: January 2027.
How MCAS overlaps with CIRS, Lyme, environmental illness, and other inflammatory conditions — shared mechanisms and shared patterns. Anticipated release: January 2027.
An introductory overview of mast cell activation syndrome — what mast cells do, how they become dysregulated, and what that means for health. Anticipated release: January 2027.
A foundational course for patients navigating mast cell activation — understanding the landscape and building a knowledge base. Anticipated release: January 2027.
Exploring the triggers that activate mast cells and the patterns of activation seen in mast cell dysregulation. Anticipated release: January 2027.
Educational content only. Biotoxin University does not provide medical advice, diagnosis, treatment, lab interpretation, or environmental clearance decisions. Consult qualified professionals for personal decisions.